All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 165 of 206 pages ‹ First < 163 164 165 166 167 > Last ›
HSL7952
McAllister JC.
Fortresses and formularies: response 3
American Journal of Health System Pharmacy 2000 May 1;57:859-860
HSL6936
Kollek D.
How advertisements have changed
Canadian Family Physician 2000 May;46:1025-1026
HSL7822
Cooper W.
Drug wars, episode two: health plans strike back
Pharmaceutical Executive 2000 May;110, 112, 114
HSL7826
Wechsler J.
Congressional concerns
Pharmaceutical Executive 2000 May;20:22, 24, 26, 28
HSL7851
Smeaton J.
To market, to market
Australian Journal of Pharmacy 2000 May;81:470-471
HSL19542
Pomper S
Drug Rush: Why the Prescription Drug Market is Unsafe at High Speeds
Washington Monthly 2000 May
http://www.washingtonmonthly.com/features/2000/0005.pomper.html
HSL20139
Jeffries M
The mark of Zorro
Pharmaceutical Marketing 2000 May;
HSL18016
Mann RD, Pearce GL, Dunn N, Shakir S.
Sedation with 'non-sedating' antihistamines: four prescription-event monitoring studies in general practice - Commentary: Reporting of adverse events is worth the effort
BMJ 2000 Apr 29;320:(7243):1184-6
http://www.bmj.com/cgi/content/full/320/7243/1184?view=long&pmid=10784544
HSL19543
Gerth J, Stolberg SG
Drug Companies Profit From Research Supported by Taxpayers
The New York Times 2000 Apr 23
http://partners.nytimes.com/library/national/science/health/042300hth-drugs.html
HSL19544
Mullins CD, Palumbo F, Stuart B,
The Impact of Pipeline Drugs on Pharmaceutical Spending
Center on Drugs and Public Policy University of Maryland School of Pharmacy 2000 Apr 13
www.ahipresearch.org/PDFs/25_ExecSumImpactofPipelineDrugs.pdf
HSL19545
Henney J
The Drug Industry’s Performance In Finishing Postmarketing Research (Phase IV) Studies
Public Citizen 2000 Apr 13
http://www.citizen.org/hrg1520
HSL7931
Gebhart F.
They shoot! They score! Rx scoreboard
Drug Topics 2000 Apr 3;144:31-32, 35-36, 39
HSL5303
Medical Research Council
A framework for development and evaluation of RCTs for complex interventions to improve health
: Medical Research Council 2000 Apr 1
http://www.mrc.ac.uk/prn/pdf-mrc_cpr.pdf
HSL2588
Sarmiento A.
Medicine and industry: The payer, the piper, and the tune
Annales CRMCC 2000 Apr;33:(3):144-149
HSL3705
Bell RA, Kravitz RL, Wilkes MS.
Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals.
J Fam Pract 2000 Apr;49:(4):329-35
http://www.jfponline.com/Pages.asp?AID=2488
HSL6935
Barros JA.
[(Mis)information on drugs: the double standard practiced by pharmaceutical companies]
Cad Saude Publica. 2000 Apr-Jun;16:(2):421-7
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2000000200012&tlng=es&lng=en&nrm=iso
HSL19546
Department of Health & Human Services
Prescription Drug Coverage, Spending, Utilization, and Prices
2000 Apr
http://aspe.hhs.gov/health/reports/drugstudy/
HSL19547
Greene J
Drug Reps Targeting Nonphysicians
American Medical News 2000 Mar 27
http://www.ama-assn.org/amednews/2000/03/27/prl20327.htm
HSL2585
Sharp D.
Drug industry code proposed on "ghost" writing
Lancet 2000 Mar 25;355:1084
HSL7925
Prescriptions benefits for America's elderly
Lancet 2000 Mar 25;355:1027
HSL7930
Conlan MF.
Consumers speak out
Drug Topics 2000 Mar 20;144:71-72, 74, 77-78, 81
HSL179
Willman D.
Fears Grow Over Delay in Removing Rezulin Health: Five FDA physicians say the lives of diabetes patients are at stake. Company's conduct in development of the drug also comes under fire.
The Los Angeles Times 2000 Mar 10
HSL6932
Armstrong K, Asch DA.
Direct sale of sildenafil (Viagra) to consumers over the Internet (3rd of 3 letters)
New England Journal of Medicine 2000 Mar 9;342:(10):742
HSL6933
deKieffer DE.
Direct sale of sildenafil (Viagra) to consumers over the Internet.
N Engl J Med 2000 Mar 9;342:(10):742
HSL6934
Henney JE, Shuren JE.
Direct sale of sildenafil (Viagra) to consumers over the Internet.
N Engl J Med 2000 Mar 9;342:(10):740,
HSL11548
Miller D, Dinan W.
The Rise of the PR Industry in Britain, 1979-98
European Journal of Communication 2000 Mar 1;15:(1):5-35
http://ejc.sagepub.com/cgi/content/abstract/15/1/5
HSL2604
Press E, Washburn J.
The kept university
Atlantic Monthly 2000 Mar39-42, 44-52, 54
www.theatlantic.com/issues/2000/03/press.htm
HSL6926
Wilkes MS, Bell RA, Kravitz RL.
Direct-to-consumer prescription drug advertising: trends, impact, and implications.
Health Aff (Millwood) 2000 Mar-Apr;19:(2):110-28
http://content.healthaffairs.org/cgi/reprint/19/2/110
HSL6929
Lexchin J.
Plus ça change.
Canadian Family Physician 2000 Mar;46:532-6
HSL6930
Lexchin J.
Re: the promotion of Augmentin (amoxycillin/clavulanate)
2000 Mar;
HSL7893
Edlin M.
Health plans rein in formulary costs
Managed Healthcare 2000 Mar;10:30-32, 48
HSL18012
Rettig RA.
The industrialization of clinical research.
Health Aff (Millwood) 2000 Mar-Apr;19:(2):129-46
http://content.healthaffairs.org/cgi/reprint/19/2/129
HSL18014
Falkenberg T, Tomson G.
The World Bank and pharmaceuticals.
Health Policy Plan 2000 Mar;15:(1):52-8
http://heapol.oxfordjournals.org/cgi/reprint/15/1/52?view=long&pmid=10731235
HSL224
Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, Stevens R.
Systematic reviews and meta-analyses on treatment of asthma: critical evaluation.
BMJ 2000 Feb 26;320:(7234):537-40
http://bmj.bmjjournals.com/cgi/content/full/320/7234/537
HSL6928
Angell M, Utiger RD, Wood AJ.
Disclosure of authors' conflicts of interest: a follow-up.
N Engl J Med 2000 Feb 24;342:(8):586-7
HSL8948
Consumer Project on Technology
Additional notes on government role in the development of HIV/AIDS drugs
Washington, DC: Consumer Project on Technology 2000 Feb 23
http://www.cptech.org/ip/health/aids/gov-role.html
HSL18010
Anis AH.
Pharmaceutical policies in Canada: another example of federal-provincial discord.
CMAJ 2000 Feb 22;162:(4):523-6
http://www.cmaj.ca/cgi/content/full/162/4/523
HSL177
Willman D.
Key Physician Urges Rezulin Be Withdrawn Medicine: FDA official says 'preventable liver failure' may occur if diabetes pill remains on market. The number of injuries and deaths linked to drug rises.
The Los Angeles Times 2000 Feb 19
HSL1858
Damur C, Steurer J.
[Do physicians interpret therapy outcome differently than students?]
Schweiz Med Wochenschr 2000 Feb 12;130:(6):171-6
HSL2090
Hemminki E, McPherson K.
Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease.
Lancet 2000 Feb 12;355:(9203):566-9
http://linkinghub.elsevier.com/retrieve/pii/S0140673699034327
HSL7943
Levy S.
First DTC drug ads of 2000 promote a wide assortment
Drug Topics 2000 Feb 7;144:120, 122
HSL7944
Chi J.
Drug budget spiraling out of control? Here's how to rein in your costs
Drug Topics 2000 Feb 7;144:64
HSL7896
Smeaton J.
Moving pictures
Australian Journal of Pharmacy 2000 Feb;81:128-129
HSL18011
Carne X, Arnaiz JA.
Methodological and political issues in clinical pharmacology research by the year 2000.
Eur J Clin Pharmacol 2000 Feb-Mar;55:(11-12):781-5
http://www.ncbi.nlm.nih.gov/pubmed/10805054
HSL6927
Hailey D.
Scientific harassment by pharmaceutical companies: time to stop.
CMAJ 2000 Jan 25;162:(2):212-3
http://www.cmaj.ca/cgi/content/full/162/2/212 and http://www.cmaj.ca/cgi/content/full/162/2/212
HSL20122
Pharmaceutical companies taken to court for forbidden drug advertising
The Volkskrant 2000 Jan 227
HSL2152
Wazana A.
Physicians and the pharmaceutical industry: is a gift ever just a gift?
JAMA 2000 Jan 19;283:(3):373-80
http://jama.ama-assn.org/cgi/content/full/283/3/373
HSL2580
Tenery RM Jr.
Interactions between physicians and the health care technology industry.
JAMA 2000 Jan 19;283:(3):391-3
http://jama.ama-assn.org/cgi/content/full/283/3/391
HSL14719
Zablocki E.
Drug Company Gifts May Affect the Way Doctors Practice Medicine
WebMD 2000 Jan 18
http://www.webmd.com/news/20000118/drug-company-gifts-may-affect-way-doctors-practice-medicine
HSL7956
Gebhart F.
Flush with victory, compounding pharmacists see demand soar
Drug Topics 2000 Jan 17;144:28, 31
HSL7907
Reissner D.
Pharmacy on the Net: is it legal?
Chemist and Druggist 2000 Jan 15;253:20
HSL7949
Levy S.
Marketing switch
Drug Topics 2000 Jan 3;144:36
HSL220
Lovdahl U, Riska E.
The construction of gender and mental health in Nordic psychotropic-drug advertising.
Int J Health Serv 2000;30:(2):387-406
HSL235
Angell M.
The pharmaceutical industry--to whom is it accountable
N Engl J Med 2000;342:1902-1904
http://content.nejm.org/cgi/content/extract/342/25/1902
HSL2635
Maestri E, Furlani G, Suzzi F, Campomori A, Formoso G, Magrini N.
So much time for so little: Italy's pharmaceutical industry and doctors' information needs.
BMJ 2000 Jan 1;320:(7226):55-6
http://bmj.com/cgi/content/full/320/7226/55
HSL2078
Robinson P, Heywood P.
What do GPs need to know? The use of knowledge in general practice consultations.
Br J Gen Pract 2000 Jan;50:(450):56-9
http://www.ingentaconnect.com/content/rcgp/bjgp/2000/00000050/00000450/art00016?token=00601ae60a99037bb575686f3a576b3427656c3c6a334025757d5c4f7e41225f406a592c494673482825734523ac65ff
HSL7912
Smith DL.
Don't forget about us after the initial DTC ad
Pharmaceutical Executive 2000 Jan;20:113
HSL7913
West D.
Dialing for DTC: operation 1-800-call center gets the scoop
Pharmaceutical Executive 2000 Jan;20:98-100, 102, 104, 106
HSL225
Guldal D, Semin S.
The influences of drug companies' advertising programs on physicians
Int J Health Serv 2000;30:(3):585-95
HSL1496
Cialdini RB.
Influence: Science and Practice 4th Edn
New York: Allyn & Bacon 2000
http://www.ablongman.com/catalog/academic/product/0,1144,0321011473,00.html
HSL1847
Pearson S, Smith AJ, Rolfe IE, Moulds RF, Shenfield GM.
Intern Prescribing for Common Clinical Conditions.
Adv Health Sci Educ Theory Pract 2000;5:(2):141-150
http://www.springerlink.com/app/home/contribution.asp?wasp=e0f7248c20da438d88ea51c792f37dae&referrer=parent&backto=issue,6,7;journal,16,26;linkingpublicationresults,1:102840,1
HSL1854
Candy PC.
Preventing "information overdose": developing information-literate practitioners.
J Contin Educ Health Prof 2000 Fal;20:(4):228-37
HSL2038
Braithwaite J, Drahos P.
Global business regulation.
Cambridge: Cambridge University Press 2000
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521784999
HSL2054
Sutherland M, Sylvester AK.
Advertising and the Mind of the Consumer 2nd Ed: What works, what doesn't, and why.
Sydney: Allen & Unwin 2000
http://www.allen-unwin.com.au/Shopping/SearchResults.aspx?search=Advertising+and+the+Mind+of+the+Consumer+
HSL2242
Roughead L, Semple S, Vitry A.
The Value of Pharmacist Professional Services in the Community: A systematic review of the literature 1990-2002
2000
HSL2317
Freemantle , N. JOHNSSON, R. , Dennis J., Kennedy , A. MARCHMENT, M
Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/ industry intervention to influence prescribing practice.
British Journal of Clinical Pharmacology 2000;49:174-179
HSL2581
Sweet M.
Medicines and the media: a journalist's view
Australian Prescriber 2000;23:(4):70-1
http://www.australianprescriber.com
HSL2592
Roughead L, Gilbert A.
Medicines and the media
Australian Prescriber 2000;23:(6):115
http://www.australianprescriber.com
HSL2625
Morgan S, Barer M, Evans R.
Buying science, selling drugs
Health Matters 2000;43:12-13
HSL3696
Slaughter E, Schumacher M.
Prevention’s international survey on wellness and consumer reactions to DTC Advertising of Rx drugs
Prev Mag 2000;
HSL5343
Kohn LT, Corrigan JM, Donaldson MS, .
To Err Is Human: Building a Safer Health System
Washington, DC: National Academies Press 2000
HSL5426
Baron J.
Thinking and Deciding 3rd edn
Cambridge: Cambridge University Press 2000
HSL6205
Sparrow MK.
The regulatory craft: Controlling risks, solving problems and managing compliance
Washington: The Brookings Institution 2000
HSL6920
Ala-fossi N, Vilhunen S, Lilja J, Enlund H.
Promoting antidepressants to physicians in Finnish direct mail and journal advertisements
Journal of Social and Administrative Pharmacy 2000;17:9-14
HSL6921
Day R.
How to make the most of a visit from a pharmaceutical company representative
Australian Prescriber 2000;23:(5):97-99
http://www.australianprescriber.com
HSL6922
Dennis RJ.
Drug promotion: Does the right hand know what the left is doing?
Pharmacoepidemiology and Drug Safety 2000;9:291-292
HSL6923
Kopp SW, Bang HK.
Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications
Health Mark Q 2000;17:(3):39-56
HSL6924
Lexchin J.
Double standards: Double jeopardy
Pharmacoepidemiology and Drug Safety 2000;9:289-290
HSL6925
Lovdahl U, Riska E.
The construction of gender and mental health in Nordic psychotropic-drug advertising.
Int J Health Serv 2000;30:(2):387-406
HSL6931
Duncan B, Miller S, Sparks J.
Exposing the mythmakers
Family Therapy Networker 2000;24:(2):24-33, 52-53
http://web.archive.org/web/20080726120502/http://www.angelfire.com/co2/counseling/drugs-depression.html
HSL6942
Lalonde A.
Selling, or selling out? [response]
Journal of the Society of Obstetricians and Gynaecologists of Canada 2000;22:(7):497
HSL6951
Bodenheimer T.
Clinical investigators and the pharmaceutical industry (3rd of 3 letters)
New England Journal of Medicine 2000;343:(7):511
http://content.nejm.org/cgi/content/full/343/7/510
HSL6952
Diamond C.
Is academic medicine for sale? (9th of 13 letters)
New England Journal of Medicine 2000;343:(7):510
http://content.nejm.org/cgi/content/full/343/7/508
HSL7257
Smith BL, Korn D.
Is there a crisis of accountability in the American research university?
Minerva 2000;38:(2):129-45
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Display&DB=pubmed
HSL7848
Soller RW.
OTCs 2000: achievements and challenges
Drug Information Journal 2000;34:(3):693-701
HSL7849
Morris LA, Pines WL.
Regulation of pharmaceutical promotion in the twenty-first century
Drug Information Journal 2000;34:(3):861-873
HSL7850
Rosati S.
Community pharmacy and SB393
California Pharmacist 2000;47:(2):20
HSL7885
Kizer JR, Kimmel SE.
Calcium channel blocker controversy: historical perspective and important lessons for future pharmacotherapies-International Society of Pharmacoepidemiology hot topic
Pharmacoepidemiology and Drug Safety 2000;9:(1):25-36
HSL7886
Nolan A.
Pharmaceutical advertising in clinical software
Australian Prescriber 2000;23:(3):52-53, 67
HSL7887
Letendre W, Jackson R.
Marketing your prescription compounding practice. Part 3
International Journal of Pharmaceutical Compounding 2000;4:(3):199-202
HSL7908
Desselle SP, Aparasu R.
Attitudinal dimensions that determine pharmacists' decisions to support DTCA of prescription medication
Drug Information Journal 2000;34:(1):103-114
HSL7916
Breu J.
Higher utilization, new products driving prescription spending
Drug Topics 2000;144:
HSL19379
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, For the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
Meta-analysis of observational studies in epidemiology: a proposal for reporting.
JAMA 2000 19;283:(15):2008
http://jama.ama-assn.org/content/283/15/2008.long
HSL11552
Mills F.
Patient groups and the Global Pharmaceutical Industry
London: URCH publishing 2000
http://www.amazon.com/Pharmaceutical-Industry-Importance-Directly-Consumer/dp/1859784267/ref=sr_1_1/102-5869202-0212934?ie=UTF8&s=books&qid=1190547090&sr=1-1
HSL13264
Brucks M, Zeithaml VA, Naylor G.
Price and Brand Name As Indicators of Quality Dimensions for Consumer Durables
Journal of the Academy of Marketing Science 2000 Summer;28:(3):359-374
http://jam.sagepub.com/cgi/content/abstract/28/3/359
HSL13274
Gigerenzer G, Todd PM, and ABC Research Group
Simple Heuristics That Make Us Smart
: Oxford University Press 2000
http://www.oup.com/uk/catalogue/?ci=9780195143812#desc
HSL14746
Liebman M.
Listen Up, Publishers Say - Journal Advertising Sells!
Medical Marketing & Media 2000;35:(3):89-94
http://www.rxpromoroi.org/add_reading/listenup.html
HSL15823
Rodwin MA, Okamoto E.
Physicians' Conflicts of Interest in Japan and the United States: Lessons for the United States
Journal of Health Politics, Policy and Law 2000;25:(2):343-376
http://jhppl.dukejournals.org/cgi/content/abstract/25/2/343
HSL19400
Mansfield PR
Year of graduation, level of 'scepticism' and attendance at sponsored meetings are significant predictors of General Practioners' beliefs about the appropriateness of drugs
2000;
http://www.healthyskepticism.org/global/news/int/hsin2010-05
HSL16003
Santos LA.
AGENCIFICAÇÃO, PUBLICIZAÇÃO, CONTRATUALIZAÇÃO E CONTROLE SOCIAL: POSSIBILIDADES NO ÂMBITO DA REFORMA DO
2000
http://diap.ps5.com.br/file/655.pdf
Page 165 of 206 pages ‹ First < 163 164 165 166 167 > Last ›
